Search results
Two Biosimilars Approved in Europe for Autoimmune Disorders
Medscape· 3 days agoThe drugs are intended to treat several types of arthritis, psoriasis, COVID-19, and Crohn's...
Arthritis Medications: NSAIDs, Steroids, Narcotics, Topical Treatments, and More
WebMD· 4 days agoThere are dozens of medications available with or without a prescription to treat the various forms of arthritis. Nonsteroidal anti-inflammatory drugs or ...
These Pictures Will Help You Identify the Most Common Skin Rashes
Prevention via Yahoo News· 3 days agoFrom eczema to allergic reactions to bug bites, here’s what common skin rashes look like in photos,...
Op-ed: Here are 6 health-care stocks to watch now, amid a bumpy recovery
CNBC· 5 days agoHealth care, long an ailing stock market sector, has recovered over the past six months, with...
Takeda Pharmaceutical: A Long-Term Cash Cow
GuruFocus.com via Yahoo Finance· 6 days agoFurthermore, the Japanese company has a rich pipeline of experimental drugs whose effectiveness and safety profile are assessed in dozens of pivotal...
Novartis (NVS) Q1 Earnings, Sales Beat, Guidance Raised
Zacks via Yahoo Finance· 6 days agoOctober 2023, the FDA approved Cosentyx for treating moderate-to-severe hidradenitis suppurativa...
Alvotech Announces Topline Results from a Confirmatory Clinical Study for AVT05, a Proposed...
Benzinga· 5 days agoThe confirmatory clinical safety and efficacy study for AVT05, biosimilar candidate to Simponi® and Simponi Aria® (golimumab), met its primary endpoint in patients with moderate to severe rheumatoid
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Ventyx...
Morningstar· 23 hours agoPomerantz LLP announces that a class action lawsuit has been filed against Ventyx Biosciences, Inc. ("Ventyx" or the "Company") (NASDAQ: VTYX) and certain officers. The class action, filed in ...
AbbVie (ABBV) to Release Quarterly Earnings on Friday
ETF DAILY NEWS· 4 days agoAbbVie (NYSE:ABBV – Get Free Report) is scheduled to be issuing its quarterly earnings data before the market opens on Friday, April 26th. Analysts expect the company to announce earnings of ...
Barrington Research Reaffirms Outperform Rating for Option Care Health (NASDAQ:OPCH)
ETF DAILY NEWS· 1 day agoBarrington Research restated their outperform rating on shares of Option Care Health (NASDAQ:OPCH –...